Cancer pharmacogenomics: achievements in basic research
- PMID: 15729595
- DOI: 10.1007/s10147-004-0463-8
Cancer pharmacogenomics: achievements in basic research
Abstract
Pharmacogenomics is the study of how genetic inheritance influences the responses to drugs. Genetic polymorphisms in drug-metabolizing enzymes result in altered pharmacokinetics in therapeutic drugs. In recent years, there has been great progress in our knowledge of the effects of cytochrome P450 (CYP) polymorphisms on the pharmacokinetics of therapeutic drugs. CYP enzymes catalyze the activation or detoxification of several anticancer drugs. Anticancer drugs generally have a narrow therapeutic margin. Therefore, the interindividual variability in their efficacy and toxicity is a major problem in clinical practice. In this review, genetic polymorphisms of CYP enzymes and their clinical relevance in cancer chemotherapy are discussed.
Similar articles
-
Cancer pharmacogenomics: international trends.Int J Clin Oncol. 2005 Feb;10(1):5-13. doi: 10.1007/s10147-004-0467-4. Int J Clin Oncol. 2005. PMID: 15729594 Review.
-
Cytochrome P450 pharmacogenetics and cancer.Oncogene. 2006 Mar 13;25(11):1679-91. doi: 10.1038/sj.onc.1209377. Oncogene. 2006. PMID: 16550168 Review.
-
Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.Eur J Cancer. 2006 Jan;42(2):141-8. doi: 10.1016/j.ejca.2005.08.035. Epub 2005 Dec 1. Eur J Cancer. 2006. PMID: 16325399 Review.
-
Polymorphism of human cytochrome P450 enzymes and its clinical impact.Drug Metab Rev. 2009;41(2):89-295. doi: 10.1080/03602530902843483. Drug Metab Rev. 2009. PMID: 19514967 Review.
-
CYP450 pharmacogenetics for personalizing cancer therapy.Drug Resist Updat. 2008 Jun;11(3):77-98. doi: 10.1016/j.drup.2008.03.002. Epub 2008 May 19. Drug Resist Updat. 2008. PMID: 18486526 Review.
Cited by
-
Principles of dose-setting in toxicology studies: the importance of kinetics for ensuring human safety.Arch Toxicol. 2021 Dec;95(12):3651-3664. doi: 10.1007/s00204-021-03155-4. Epub 2021 Oct 8. Arch Toxicol. 2021. PMID: 34623454 Free PMC article. Review.
-
Current status of pharmacogenomics testing for anti-tumor drug therapies: approaches to non-melanoma skin cancer.Mol Diagn Ther. 2009;13(2):65-72. doi: 10.1007/BF03256316. Mol Diagn Ther. 2009. PMID: 19537842 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
